Trial
NCT06039384
A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
Mirati Therapeutics Inc.
Condition
Advanced Solid Tumors
Intervention
INCB099280
Why stopped
This was a strategic business decision. There were no safety concerns contributing to this decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-03